Indivior Pharmaceuticals, Inc. INDV Business Segments — Income Tax
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's business segments — income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's business segments — income tax?
- Indivior Pharmaceuticals, Inc. (INDV) reported business segments — income tax of $26M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's business segments — income tax changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's business segments — income tax increased by 136.4% year-over-year, from $11M to $26M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's business segments — income tax?
- Over 2 years (2022 to 2024), Indivior Pharmaceuticals, Inc. 's business segments — income tax has grown at a -45.6% compound annual growth rate (CAGR), from -$44M to $13M.
- What does business segments — income tax mean?
- This reflects the total tax liability incurred by the reportable segment based on its taxable income. It is a critical component for understanding the net contribution of the segment to the company's bottom line after regulatory obligations.